Popular Weight-Loss Drug Found To Slow Biological Aging in Landmark Human Trial

Popular Weight-Loss Drug Found To Slow Biological Aging in Landmark Human Trial

A widely prescribed class of weight-loss and diabetes medications may be doing more than improving metabolic health. Drugs such as Ozempic and Wegovy have transformed the treatment of obesity and type 2 diabetes, helping millions lose weight and improve metabolic health. But scientists are increasingly uncovering effects that extend far beyond the scale. Research has [...]

Weight-loss drug may slow down signs of aging

A small study found that people taking semaglutide showed signs of slower biological aging compared with those taking a placebo.

GLP-1 therapy linked to slower biological aging processes

Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease.

Study: Popular GLP-1 Drug May Slow Down Biological Aging

A study by UC San Diego researchers and their colleagues has found that semaglutide slows down the accumulation of biological aging markers in the DNA of adults with HIV, pointing to the potential of GLP‑1 receptor agonists to help prevent age‑related diseases.

Could Ozempic Slow Aging? A New Clinical Trial Analysis Opens The Door

Millions of people already take semaglutide to lose weight or protect their hearts. A new clinical trial analysis suggests the drug may also be capable of slowing the rate at which the body biologically ages. The post Could Ozempic Slow Aging? A New Clinical Trial Analysis Opens The Door appeared first on StudyFinds.